TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study in Nature Communications links blood levels of the gut-bacteria-produced molecule imidazole propionate (ImP) with Alzheimer’s-related biological markers and faster cognitive decline. Mouse experiments found changes in abnormal amyloid and tau accumulation, but the human findings are associations and do not establish that ImP causes Alzheimer’s disease or that lowering it prevents decline.
Researchers at the University of Wisconsin–Madison and collaborators have linked imidazole propionate (ImP), a molecule made by some gut bacteria, with biological markers associated with Alzheimer’s disease and faster cognitive decline in people followed over time. The study also found in mice that ImP reaching the brain increased abnormal amyloid and tau accumulation, but the human results do not establish that the molecule causes Alzheimer’s or that reducing it would prevent the disease.
The team examined blood samples from nearly 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies run through the Wisconsin Alzheimer’s Disease Research Center. Participants with higher blood ImP concentrations were more likely to show biological markers linked to abnormal proteins and impaired neuron function. Their repeated cognitive test results also showed an association between higher ImP and faster decline in thinking and memory.
In experiments with mice, the researchers found that ImP that reached the brain increased the accumulation of abnormal beta-amyloid and tau proteins, both associated with Alzheimer’s disease. The researchers describe these animal results as evidence that ImP may affect brain processes relevant to dementia; they do not show that the same mechanism has been proven in people.
The study also identified a genetic variation associated with substantially higher ImP levels in the blood. About 43% of study participants carried the variation. The team suspects it may affect how efficiently the kidneys remove ImP, but that explanation remains a hypothesis. The findings appeared in Nature Communications; researchers from UCLA and the University of Gothenburg also contributed.
A Possible Target Beyond Diet
The findings add a possible link between the gut microbiome and brain health to a field where researchers are still working out how changes in intestinal microbes might relate to dementia. ImP is of interest because it can move from the gut into the bloodstream and, according to the mouse experiments, reach the brain. That makes it a candidate for further study as a biological pathway—not an established cause of Alzheimer’s.
If future research confirms that ImP contributes to disease processes, a treatment designed to lower the molecule could potentially offer a more specific approach than trying to remove a common nutrient from the diet. For now, the study does not show that an ImP-lowering treatment exists, works, or would reduce a person’s risk. It also does not support changing diet or medical care on the basis of these findings alone.
gut health supplements for cognitive support
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Gut Microbes to ImP
The research follows work by University of Wisconsin–Madison investigators Barbara Bendlin and Federico Rey on differences in gut microbial communities between people with Alzheimer’s and healthy individuals. Their newer study focused on ImP, which is made by certain bacteria as they generate energy from histidine, an amino acid people need and obtain from food.
ImP production varies considerably among people. According to Rey, bacteria capable of producing it are found in many people but generally are not abundant. Previous research has linked ImP with type 2 diabetes and coronary artery disease; the new paper investigates possible associations with brain-related measures. Because histidine is present in many foods, the researchers cautioned that avoiding particular protein-rich foods is not a straightforward way to control ImP.
““Since then, we’ve been trying to figure out how this difference in the gut perhaps leads to changes in the brain.””
— Barbara Bendlin, University of Wisconsin–Madison professor of medicine, as quoted in the ScienceDaily report
As an affiliate, we earn on qualifying purchases.
Association Is Not Causation
The human data show that ImP levels and Alzheimer’s-related measures occur together; they do not establish whether ImP contributes to cognitive decline, results from other biological changes, or reflects additional factors. The mouse findings offer a possible mechanism but cannot, by themselves, demonstrate the same effect in people or predict whether changing ImP would alter disease outcomes.
It is also not yet clear how the genetic variation affects ImP levels, whether kidney clearance is the reason, or whether lowering ImP would be safe and effective. The report does not provide a tested dietary method, a clinical threshold for high ImP, or evidence that people should seek testing. The reported 43% figure describes participants carrying the variation in this study, not the share of the general population known to have it.
detox supplements for gut bacteria
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing ImP-Lowering Strategies
The next steps are to test the proposed links in further research, clarify how the genetic variation relates to ImP in the blood, and determine whether the molecule directly affects human brain processes. Researchers also need to establish whether an intervention can lower ImP without harmful effects and whether doing so changes Alzheimer’s-related outcomes.
The team points to a possible future drug that inhibits ImP production or reduces its presence in the bloodstream, but no such treatment is established by this study. Until clinical evidence is available, the reported work is best understood as identifying a research target, not a prevention strategy or recommendation for individuals.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is imidazole propionate?
Imidazole propionate (ImP) is a molecule produced by certain gut bacteria as they use histidine, an amino acid. It can enter the bloodstream after being made in the gut.
Does the study prove that ImP causes Alzheimer’s disease?
No. The human results show an association between higher blood ImP and Alzheimer’s-related markers and faster cognitive decline. The study does not prove that ImP causes the disease.
Should people change what they eat to lower ImP?
The findings do not establish a diet that lowers ImP or show that dietary changes prevent Alzheimer’s. The researchers noted that histidine is needed and occurs in many foods, so avoiding one or two foods is not a demonstrated solution.
Was an ImP-lowering drug tested?
The report describes a possible future treatment target, not a proven or tested ImP-lowering therapy. Whether lowering ImP would affect Alzheimer’s risk or cognitive decline remains unknown.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
